Nicolas H. Thurin, PharmD, PhD

Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France, France

Poster(s):

• (A-357) Assessment of the Risk of 32 Adverse Effects of Special Interest following COVID-19 Vaccination in the Whole French Population
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-093) Preliminary results from a European post authorization study to assess the safety of Paxlovid among patients with moderate or severe hepatic or renal impairment
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-257) Preliminary Results from a European Post-Authorization Study to Assess the Safety of Paxlovid in Pregnancy
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET